A groundbreaking new study has uncovered that the genetic mutations responsible for cancer development in domestic cats closely mirror those found in humans, offering promising insights for future cancer therapies. Researchers from the Wellcome Sanger Institute, Ontario Veterinary College, and the University of Bern conducted an extensive analysis of tumours from nearly 500 pet cats across five different countries to identify these striking genetic parallels.
Genetic Similarities Between Feline and Human Cancers
The research specifically highlighted strong connections between feline mammary cancers and human breast cancers. Scientists identified common driver genes, such as FBXW7 and PIK3CA, that play critical roles in both species. Changes in the FBXW7 gene within cat mammary tumours, which are also present in human breast cancer cases, were associated with a poorer prognosis, reflecting similar outcomes observed in human patients.
Implications for Therapy Development
These findings suggest a significant potential for developing innovative therapies that could benefit both cats suffering from mammary carcinoma and human breast cancer patients. By understanding the shared genetic pathways, researchers can explore targeted treatments that address these common mutations, potentially leading to more effective and personalised medical interventions.
Additionally, the study enhances our comprehension of shared environmental cancer risks, as both cats and humans are exposed to similar household and environmental factors that may contribute to cancer development. This cross-species research not only advances veterinary medicine but also provides a valuable model for human oncology, accelerating progress in cancer prevention and treatment strategies.
